Identification |
Name: | Benzamide,2-[[(4-chlorophenyl)sulfonyl]amino]-4,5-dimethoxy-N-[4-(4-thiomorpholinylsulfonyl)phenyl]- |
Synonyms: | 2-[[(4-Chlorophenyl)sulfonyl]amino]-4,5-dimethoxy-N-[4-[(4-thiomorpholinyl)sulfonyl]phenyl]benzamide;S 3448 |
CAS: | 254877-04-8 |
Molecular Formula: | C25H26 Cl N3 O7 S3 |
Molecular Weight: | 0 |
InChI: | InChI=1/C25H26ClN3O7S3/c1-35-23-15-21(22(16-24(23)36-2)28-38(31,32)19-7-3-17(26)4-8-19)25(30)27-18-5-9-20(10-6-18)39(33,34)29-11-13-37-14-12-29/h3-10,15-16,28H,11-14H2,1-2H3,(H,27,30) |
Molecular Structure: |
|
Properties |
Density: | 1.485g/cm3 |
Refractive index: | 1.658 |
Usage: | A new class of sGC agonists. A novel anthranilic acid derivatives activating heme-oxidized soluble guanylyl cyclase. Useful for the therapy and prophylaxis of diseases, for example of cardiovascular diseases such as hypertension, angina pectoris, |
Safety Data |
|
|